425: Strive, Semler Scientific Merger: Cautionary Update

Strive, Inc. reposted a communication regarding its proposed business combination with Semler Scientific, Inc., emphasizing forward-looking statements and associated risks.

Summary

• Strive, Inc. (Strive) reposted a communication on X.com by its Chief Marketing Officer, Arshia Sarkhani, on December 22, 2025.
• The communication pertains to Strive's proposed business combination with Semler Scientific, Inc. (Semler Scientific).
• The document includes a cautionary statement regarding forward-looking statements, highlighting inherent risks and uncertainties associated with such statements.
• Forward-looking statements cover expectations regarding the proposed transaction, including strategic and financial benefits, timing of closing, and successful integration of combined businesses.
• Investors and stockholders of Semler Scientific are urged to thoroughly read the Registration Statement on Form S-4, Information Statement/Proxy Statement/Prospectus, and other relevant SEC filings for comprehensive information before making voting or investment decisions.

Sentiment

Score: 5

Explanation: The filing announces a proposed merger, which is generally a positive strategic move, but it is primarily a cautionary statement heavily focused on outlining numerous risks and uncertainties associated with forward-looking statements and the transaction itself. This balances the inherent positivity of a merger announcement with a strong emphasis on potential downsides and challenges.

Positives

• The proposed transaction is expected to yield strategic benefits for the combined company.
• The proposed transaction is anticipated to result in financial benefits.
• Expected cost savings are projected from the business combination.
• Anticipated strategic gains are a key driver for the proposed transaction.

Negatives

• The filing primarily focuses on potential risks and uncertainties rather than explicit negative aspects of the proposed transaction itself.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors that could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The filing indicates an outlook of strategic and financial benefits from the proposed transaction, including anticipated cost savings and strategic gains. However, it heavily cautions that these forward-looking statements are subject to significant risks and uncertainties, and actual results could differ materially from expectations.

Management Comments

• Strive and Semler Scientific believe that their expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of their existing knowledge of their business and operations.

Industry Context

The filing mentions 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets,' suggesting an involvement in or exposure to the digital asset space, which is a growing area of interest for some companies.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a potential risk.

Stakeholder Impact

• Potential adverse reactions of Strive's customers.
• Potential adverse reactions of Semler Scientific's customers.
• Changes to Strive's business or employee relationships.
• Changes to Semler Scientific's business or employee relationships.
• Dilution for Strive's Class A common stock shareholders due to additional share issuance.

Next Steps

• Semler Scientific stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus and other relevant SEC documents before making any voting or investment decision.
• Semler Scientific stockholders will be asked to approve the proposed transaction.
• Strive and Semler Scientific may file other relevant documents concerning the proposed transaction with the SEC.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Investment, Bitcoin Treasury Strategy, Digital Assets